Skip to main content

Table 2 Univariable analysis

From: Gender but not diabetes, hypertension or smoking affects infarct evolution in ST-elevation myocardial infarction patients – data from the CHILL-MI, MITOCARE and SOCCER trials

 

MaR

Infarct size

MSI

Coeff

SE

p-value

Coeff

SE

p-value

Coeff

SE

p-value

Age

0.0

0.1

0.866

0.1

0.1

0.213

− 0.2

0.1

0.059

Pain to balloon

0.0

0.0

0.262

0.0

0.0

0.512

−0.0

0.0

0.143

Female gender

−5.0

1.5

0.001

−5.0

1.4

< 0.001

9.8

2.8

0.001

Pre PCI TnT < 15 ng/L

1.0

1.3

0.419

−1.8

1.2

0.148

5.8

2.4

0.015

LVM

0.1

0.0

0.004

0.1

0.0

< 0.001

−0.2

0.0

< 0.001

LVM/BSA

0.1

0.0

0.053

0.1

0.0

0.001

−0.3

0.1

0.001

Risk factors

 Current smoker

−1.0

1.3

0.465

−2.4

1.3

0.057

3.8

2.5

0.138

 Smoker or ex-smoker

−1.5

1.3

0.237

−2.8

1.2

0.021

5.3

2.4

0.030

 Diabetes

−0.7

2.0

0.719

−0.1

1.9

0.972

0.0

3.8

0.997

 Hypertension

0.1

1.4

0.966

0.1

1.3

0.936

−0.2

2.7

0.929

Treatments

 Hypothermia

2.8

1.7

0.100

−0.2

1.6

0.882

3.0

3.2

0.357

 Oxygen

2.2

2.3

0.346

−0.2

2.2

0.940

3.7

5.0

0.467

 TRO40303

1.4

1.7

0.408

1.0

1.6

0.544

−1.7

3.2

0.603

Angiography

 Anterior injury

10.9

1.1

< 0.001

9.0

1.1

< 0.001

−9.4

2.4

< 0.001

 TIMI 0

3.5

1.5

0.019

5.7

1.3

< 0.001

−12.4

2.7

< 0.001

 Rentrop 0

−3.4

1.4

0.018

−2.0

1.4

0.139

0.4

2.7

0.894

  1. Pre PCI TnT < 15 ng/L = a blood sample acquired before coronary intervention showing a troponin T value < 15 ng/L, TRO40303 = the study treatment in the mitocare trial
  2. LVM left ventricular mass, BSA body surface area
Back to article page

BMC Cardiovascular Disorders

ISSN: 1471-2261

Contact us